Dr. Zimering is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1771 Madison Ave
Lakewood, NJ 08701Phone+1 732-364-2144
Education & Training
- National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1987 - 1990
- Clinical Center at the National Institutes of HealthResidency, Internal Medicine, 1986 - 1987
- Hennepin HealthcareResidency, Internal Medicine, 1984 - 1986
- Albert Einstein College of MedicineClass of 1984
Certifications & Licensure
- NJ State Medical License 1991 - 2025
- MD State Medical License 1986 - 1991
- MN State Medical License 1985 - 1987
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- A Serotonin 2A-Receptor Decoy Peptide Potently Lowers Blood Pressure in Male Zucker Diabetic, Fatty, Hypertensive Rats.Mark B Zimering
Endocrinology, Diabetes and Metabolism Journal. 2021-08-01 - Endothelial Cell Growth Promoting Activity in Graves' Disease Sera is Neutralized by Anti-Basic Fibroblast Growth Factor Antibodies in Patients with Fat Expansive but ...Mark B Zimering, John J Shin, Jennifer D Zaitz, Elkin A Nunez, Andrew G. Gianoukakis
Endocrinology, Diabetes and Metabolism Journal. 2019-01-08 - 5 citationsEndothelial cell autoantibodies in predicting declining renal function, end-stage renal disease, or death in adult type 2 diabetic nephropathy.Mark B Zimering, Jane H. Zhang, Peter Guarino, Nicholas V. Emanuele, Peter A. McCullough
Frontiers in Endocrinology. 2014-08-11
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: